Tilmann Schumacher

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

Christian Waldherr, Miklos Pless, Helmut R. Maëcke et al. · PubMed · 2002 · 446 citations

Medicine, Oncology, Pharmacology +15

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma

Christine Dierks, Jochen Seufert, Konrad Aumann et al. · Thyroid · 2021 · 245 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

FDG-PET imaging for the staging and follow-up of small cell lung cancer

Tilmann Schumacher, Ingo Brink, Michael Mix et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 128 citations

Medicine, Nuclear Medicine, Oncology +14

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study

Tilmann Schumacher, Silvia Höfer, Kai Eichhorn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 96 citations

Medicine, Nuclear Medicine, Oncology +16

Radiopeptide transmitted internal irradiation of non-iodophil thyroid cancer and conventionally untreatable medullary thyroid cancer using [90Y]-DOTA-D-Phe1-Tyr3-octreotide: a pilot study

Christian Waldherr, Tilmann Schumacher, Miklos Pless et al. · Nuclear Medicine Communications · 2001 · 71 citations

Medicine, Nuclear Medicine, Oncology +17